These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22137633)

  • 41. Autoantibodies in psoriasis as predictors for loss of response and anti-infliximab antibody induction.
    Hoffmann JH; Hartmann M; Enk AH; Hadaschik EN
    Br J Dermatol; 2011 Dec; 165(6):1355-8. PubMed ID: 21801160
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of severe psoriasis with anti-TNF-alpha-antibody and methotrexate].
    Dalaker M; Bonesrønning JH
    Tidsskr Nor Laegeforen; 2003 Apr; 123(8):1070-1. PubMed ID: 12760225
    [No Abstract]   [Full Text] [Related]  

  • 43. Department of Dermatology was blessed with a wonderful psoriasis specialist. Foreword.
    Feldman SR
    BioDrugs; 2013 Jan; 27 Suppl 1():1-2. PubMed ID: 23990276
    [No Abstract]   [Full Text] [Related]  

  • 44. [Ustekinumab].
    Ortonne JP
    Ann Dermatol Venereol; 2011 Dec; 138(12):848-50. PubMed ID: 22137626
    [No Abstract]   [Full Text] [Related]  

  • 45. Consecutive use of different biological therapies in the treatment of psoriasis.
    Costanzo A; Papoutsaki M; Mazzotta A; Chimenti S
    Br J Dermatol; 2007 Aug; 157(2):394. PubMed ID: 17553044
    [No Abstract]   [Full Text] [Related]  

  • 46. Long-term management of erythrodermic psoriasis with anti-TNF agents.
    Romero-Maté A; García-Donoso C; Martinez-Morán C; Hernández-Núñez A; Borbujo J
    Dermatol Online J; 2010 Jun; 16(6):15. PubMed ID: 20579470
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of recalcitrant pustular psoriasis with infliximab: effective reduction of chemokine expression.
    Benoit S; Toksoy A; Bröcker EB; Gillitzer R; Goebeler M
    Br J Dermatol; 2004 May; 150(5):1009-12. PubMed ID: 15149518
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recalcitrant, generalized pustular psoriasis: rapid and lasting therapeutic response to antitumour necrosis factor-alpha antibody (infliximab).
    Schmick K; Grabbe J
    Br J Dermatol; 2004 Feb; 150(2):367. PubMed ID: 14996114
    [No Abstract]   [Full Text] [Related]  

  • 49. Tattoo sites and psoriasis.
    Smith SF; Feldman SR
    J Drugs Dermatol; 2011 Oct; 10(10):1199-200. PubMed ID: 21968672
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advances in psoriasis treatment.
    Schön MP
    Lancet; 2005 Oct 15-21; 366(9494):1333-5. PubMed ID: 16226595
    [No Abstract]   [Full Text] [Related]  

  • 51. A promising step forward in psoriasis therapy.
    Stern RS
    JAMA; 2003 Dec; 290(23):3133-5. PubMed ID: 14679277
    [No Abstract]   [Full Text] [Related]  

  • 52. Ustekinumab: when everything else fails?
    Vitiello M; Grant A; Kerdel FA
    Int J Dermatol; 2011 Apr; 50(4):478-82. PubMed ID: 21413963
    [No Abstract]   [Full Text] [Related]  

  • 53. Guselkumab (Tremfya) for psoriasis.
    Med Lett Drugs Ther; 2017 Nov; 59(1533):179-180. PubMed ID: 29125591
    [No Abstract]   [Full Text] [Related]  

  • 54. New Injectable Drug Treats Moderate-To-Severe Plaque Psoriasis.
    Aschenbrenner DS
    Am J Nurs; 2017 Jun; 117(6):23. PubMed ID: 28541985
    [No Abstract]   [Full Text] [Related]  

  • 55. Briakinumab versus methotrexate for psoriasis.
    Malgarini RB; Pimpinella G
    N Engl J Med; 2012 Jan; 366(4):379; author reply 380. PubMed ID: 22276832
    [No Abstract]   [Full Text] [Related]  

  • 56. Briakinumab versus Methotrexate for Psoriasis.
    Wu JJ
    N Engl J Med; 2012 Jan; 366(4):379-80; author reply 380. PubMed ID: 22276833
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical experience of secukinumab in the treatment of erythrodermic psoriasis: a case series.
    Weng HJ; Wang TS; Tsai TF
    Br J Dermatol; 2018 Jun; 178(6):1439-1440. PubMed ID: 29265175
    [No Abstract]   [Full Text] [Related]  

  • 58. Psoriasis: from bed to bench and back.
    Garber K
    Nat Biotechnol; 2011 Jul; 29(7):563-6. PubMed ID: 21747375
    [No Abstract]   [Full Text] [Related]  

  • 59. Brodalumab (Siliq
    Gupta AK; Versteeg SV; Abramovits W; Vincent KD
    Skinmed; 2017; 15(4):281-285. PubMed ID: 28859739
    [No Abstract]   [Full Text] [Related]  

  • 60. Non-invasive evaluation of Secukinumab efficacy in severe plaque psoriasis with confocal microscopy and optical coherence tomography: A case report.
    Odorici G; Losi A; Ciardo S; Pellacani G; Conti A
    Skin Res Technol; 2018 Feb; 24(1):160-162. PubMed ID: 29067742
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.